Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04827225

Assessment of the Mental State of Parents of Premature Children and Impact on Neurodevelopment of the Child

Assessment of the Mental State of Parents of Premature Children and Impact on Neurodevelopment of the Child (Parents Psychic Preterm)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of the study is to assess the psychic profile of parents of children born prematurely

Detailed description

Prematurity affects aroound 1 in 10 children worlwide. Many studies have shown the role of prematurity in the development of depression, anxiety, post-traumatic stress disorder, mother-to-child attachment disorders, but few studies have sought to assess the evolution of this profile over time as well as to assess all of the parents' psychic dimensions. The investigators currently have little knowledge of risk factors (psychological or psychiatric history, follow-up undertaken, treatments implemented, etc.) that may favor the occurrence of postpartum mental disorders (anxiety, depression, post-traumatic stress disorder ). The investigators will thus seek to identify them. Prematurity can have a negative impact on the parents' psychic experience in the postpartum period. However, few studies have examined the evolution over time of the parental psychic profile and its possible repercussions on the child in terms of attachment and becoming neurodevelopmental. Finally, the majority of studies dealing with these subjects concern only mothers.Tthe investigators will endeavor here to also take into account the fathers.

Conditions

Interventions

TypeNameDescription
BEHAVIORALquestionnairesQuestionnaires (EPDS, HADS, PPQ, MIBS, etc.) will have to be completed by the parents at different stages of their child's development (38 weeks of amenorrhea, 3 months and 24 months).

Timeline

Start date
2020-10-26
Primary completion
2024-04-26
Completion
2026-08-26
First posted
2021-04-01
Last updated
2026-03-04

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04827225. Inclusion in this directory is not an endorsement.